Health-Related Physical Fitness Level From Smartwatches
NCT ID: NCT06805422
Last Updated: 2025-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
80 participants
OBSERVATIONAL
2025-01-01
2025-12-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Digitalization of Measuring Physical Performance
NCT06564350
Effect of Physical Activity Pattern on Cardiometabolic Health
NCT05838508
Characterisation of Objectively Measured Physical Activity and Self-reported Habitual Exercise
NCT05250700
The Relationship Between Exercise Frequency, Intensity, and Restoration of Cardiometabolic Health
NCT03376685
How Exercise Signals Health Responses
NCT04307212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Current advances in wearables may allow us to estimate the fitness level for all HRPF domains using only smartwatch data, enabling economic, non-intrusive predictions and being available during the user's daily routine. The complete characterization of health-related fitness as a multidimensional depiction of the user's fitness status can be used to track health status continuously and to design specialized training prescriptions. The main goal of this study is to estimate the fitness level for all HRFP domains from data obtained from smartwatches during unsupervised activities of daily living. We hypothesized that data from smartwatches could be used to estimate the fitness levels from all HRPF domains.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aerobically trained
actively engaged in aerobic exercise training for at least 2 years
No interventions assigned to this group
Strength trained
actively engaged in weight training
No interventions assigned to this group
Not actively training
not engaged in regular aerobic or weight training exercise
No interventions assigned to this group
Highly flexible
determined by their flexibility scores
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 20-60 years old
* actively training or competing over the past 2 years
* 3 or more days of vigorous activity accumulating approximately least 1500 MET min/week or 7 days of any combination of walking, moderate, or vigorous intense activities achieving a minimum of 3000 MET min/week
Group 2 (Strength trained)
* 20-60 years old
* actively training or competing over the past 2 years
* 3 or more days of muscle-strengthening exercise at an intensity of approximately 5 out of 10
Group 3 (Not actively training)
* 20-60 years old
* actively training or competing over the past 2 years
* 3 or more days of muscle-strengthening exercise at an intensity of approximately 5 out of 10
Group 5 (High flexibility)
* 20-60 years old
* Sit-and-reach performance is categorized as "very good" or excellent based on the American College of Sports Medicine's sit-and-reach evaluation criteria (Table 4.16 of ACSM's Guidelines for Exercise Testing and Prescription 9th edition).
Exclusion Criteria
* History of stable or unstable angina
* History of cardiac dysrhythmias causing symptoms or hemodynamic consequences
* History of hypertrophic cardiomyopathy
* History of cardiac valvular disease (e.g., aortic stenosis)
* History of pulmonary disease (Chronic obstructive pulmonary disease, asthma, interstitial lung disease, or cystic fibrosis)
* History of pulmonary embolus
* History of suspected or known aneurysm
* History of metabolic disease (Diabetes mellitus (type I or II), thyroid disorders, renal or liver disease
* History of renal disease
* History of neuromotor, musculoskeletal, or rheumatoid disorders that are exacerbated by exercise
* Current acute systemic infection, accompanied by fever and body aches.
* Pain or discomfort in the chest, neck, jaw, arms, or other areas that may be due to myocardial ischemia (lack of adequate circulation)
* Shortness of breath at rest, during daily activities, or with mild exertion
* Dizziness or syncope (fainting)
* Orthopnea (breathing discomfort when not in an upright position) or paroxysmal nocturnal dyspnea (interrupted breathing at night)
* Ankle edema (swelling)
* Palpitations (abnormal rapid beating of the heart) or tachycardia (rapid heartbeat)
* Intermittent claudication (cramping pain and weakness in legs, especially calves, during walking due to inadequate blood supply to muscles)
* Known heart murmur (atypical heart sound indicating a structural or functional abnormality)
* Unusual or unexplained fatigue
* Severe arterial hypertension (i.e., systolic blood pressure of \>200 mm Hg and/or a diastolic blood pressure of \>110 mm Hg) at rest.
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kansas State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carl Ade, M.S., Ph.D.
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kansas State Univeristy
Manhattan, Kansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-12223
Identifier Type: OTHER
Identifier Source: secondary_id
KansasSU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.